Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. monthly Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E12.52 EPS (ttm)2.86 Insider Own0.03% Shs Outstand5.60B Perf Week-5.01%
Market Cap200.68B Forward P/E11.37 EPS next Y3.15 Insider Trans0.26% Shs Float5.53B Perf Month-11.13%
Income16.27B PEG1.38 EPS next Q0.73 Inst Own72.80% Short Float1.10% Perf Quarter-3.68%
Sales51.75B P/S3.88 EPS this Y-11.90% Inst Trans-0.95% Short Ratio2.87 Perf Half Y3.58%
Book/sh11.74 P/B3.05 EPS next Y8.53% ROA7.90% Target Price42.54 Perf Year-15.05%
Cash/sh1.62 P/C22.08 EPS next 5Y9.10% ROE20.50% 52W Range33.97 - 44.56 Perf YTD-8.50%
Dividend1.52 P/FCF48.58 EPS past 5Y1.00% ROI10.20% 52W High-20.04% Beta0.61
Dividend %4.24% Quick Ratio0.70 Sales past 5Y0.80% Gross Margin80.70% 52W Low4.89% ATR0.67
Employees92400 Current Ratio0.90 Sales Q/Q-4.60% Oper. Margin24.20% RSI (14)26.06 Volatility1.47% 1.77%
OptionableYes Debt/Eq0.81 EPS Q/Q98.20% Profit Margin24.40% Rel Volume1.23 Prev Close35.85
ShortableYes LT Debt/Eq0.55 EarningsJan 28 BMO Payout62.80% Avg Volume21.27M Price35.63
Recom2.50 SMA20-5.73% SMA50-7.85% SMA200-8.31% Volume14,470,459 Change-0.61%
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Feb-21-20 11:10AM  Pharmaceutical companies develop system to better track counterfeit drugs Reuters
10:03AM  Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval Zacks
09:16AM  3 Best Drugmakers That Are Immune to Coronavirus Fright Zacks
Feb-20-20 11:42AM  Nations largest insurer invests in Waltham healthcare AI startup American City Business Journals
11:11AM  Dow down 75 points on losses for shares of Intel, UnitedHealth MarketWatch
Feb-19-20 09:23AM  Pfizer's Cardiomyopathy Drug Vyndaqel Gets Approval in Europe Zacks
Feb-18-20 11:24AM  Mylan-Upjohn merger filings contemplate coronavirus impact American City Business Journals
10:00AM  AbbVie's $63 Billion Allergan Takeover Is Looming Is It Time To Add Shares? Investor's Business Daily
08:00AM  Pfizer Stock Tumbled On Lackluster Earnings Should You Add Shares? Investor's Business Daily
07:37AM  The Triangle's big slice of NC bio/pharma pie List Insights American City Business Journals
06:45AM  European Commission Approves VYNDAQEL®, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Business Wire
Feb-14-20 08:00PM  Wall Street Views on Shopify, Pfizer, Quotient Tech, CN Railway, Lithia Motors Barrons.com
06:24PM  Pfizer-backed biopharma company Imara files for IPO MarketWatch
06:10PM  IBM, Caterpillar share losses contribute to Dow's 75-point fall MarketWatch
12:55PM  IBM, Caterpillar share losses contribute to Dow's 75-point fall MarketWatch
Feb-13-20 05:36PM  US Indexes Close Lower Thursday GuruFocus.com
03:32PM  Cisco, Dow Inc. share losses contribute to Dow's 100-point drop MarketWatch
02:04PM  Cisco, Dow Inc. share losses lead the way, but Dow flat MarketWatch
09:45AM  Dow's nearly 100-point drop led by losses for shares of Cisco, Dow Inc. MarketWatch
Feb-12-20 11:10AM  Pfizer's Xtandi Improves OS Rate in Prostate Cancer Study Zacks
10:30AM  Buy AbbVie for its Growth Prospects, Yield and Low Valuation GuruFocus.com
Feb-11-20 10:38AM  The Zacks Analyst Blog Highlights: Microsoft, JP Morgan Chase and Pfizer Zacks
08:00AM  XTANDI® (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER Trial of Patients with nmCRPC PR Newswire
07:23AM  The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology Benzinga
Feb-09-20 12:00AM  The onetime Parisian street fighter who gave his company purpose Financial Times
Feb-07-20 11:21AM  Blueprint Medicines' NDA for Avapritinib Gets Extended Review Zacks
Feb-06-20 05:36PM  J&J Brand Most Valuable Among Pharmaceutical Companies GuruFocus.com
03:45PM  Bristol-Myers' (BMY) Q4 Earnings & Revenues Beat Estimates Zacks
11:00AM  Glaxo (GSK) Lags Q4 Earnings & Revenue Estimates, Stock Down Zacks
06:59AM  Bristol-Myers earnings rise due to Celgene deal Reuters
Feb-05-20 11:11AM  Novo Nordisk (NVO) Q4 Earnings Match Estimates, Revenues Beat Zacks
09:15AM  Stocks - GM Rises in Premarket; Merck Falls on Spin-Off News Investing.com
07:15AM  Glaxo says adjusted EPS slips as it prepares to split into two companies MarketWatch
Feb-04-20 10:24AM  Merck's Recarbrio Gets FDA Priority Review for New Indication Zacks
10:13AM  Will Opdivo & Eliquis Drive Bristol-Myers (BMY) Q4 Earnings? Zacks
07:33AM  The Zacks Analyst Blog Highlights: Amazon.com, Procter & Gamble, Pfizer, Southwest Airlines and Humana Zacks
Feb-03-20 07:04PM  3 Dividend-Paying Stocks for Investors to Buy to Fight Off Market Uncertainty Zacks
05:42PM  Bristol-Myers' Opdivo-Yervoy NSCLC Application in EU Withdrawn Zacks
02:25PM  Q4 Earnings Scorecard and Analyst Reports for Amazon, Pfizer & Others Zacks
10:09AM  Is a Disappointment in Store for Glaxo's (GSK) Q4 Earnings? Zacks
Jan-31-20 04:53PM  Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study Zacks
10:41AM  Earnings Miss: Pfizer Inc. Missed EPS By 16% And Analysts Are Revising Their Forecasts Simply Wall St.
10:32AM  Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative Zacks
10:15AM  Bayer Seeks FDA Approval for New Formulation of Nifurtimox Zacks
09:00AM  Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE (rituximab) Business Wire
07:30AM  Bayer wins EU recommendation for prostate cancer drug Reuters
Jan-30-20 09:57AM  Dow's 75-point fall led by losses in shares of Dow Inc., Verizon Communications Inc. MarketWatch
Jan-29-20 08:56AM  Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More Zacks
Jan-28-20 09:12PM  Edited Transcript of PFE earnings conference call or presentation 28-Jan-20 3:00pm GMT Thomson Reuters StreetEvents -5.03%
04:58PM  Dow closes higher to snap 5-day losing streak after worst single session loss since October MarketWatch
04:35PM  Stock Market Today: Earnings Season Gets Intense; Buy Uber? InvestorPlace
04:20PM  Dow Jones Today: Stocks Return From the Coronavirus Abyss InvestorPlace
04:16PM  US STOCKS-Apple sparks Wall St bounce ahead of results Reuters
04:01PM  Why Dow Jones Pharma Giant Pfizer Is Close To Triggering A Sell Rule Investor's Business Daily
03:00PM  US STOCKS-Apple leads Wall St rebound ahead of results Reuters
02:36PM  Merck's Dificid Gets FDA Approval in Pediatric Indication Zacks
01:54PM  Apple, Starbucks & eBay Earnings Previews & A Strong Buy Retail Stock - Free Lunch Zacks
01:05PM  US STOCKS-Wall Street rebounds as Apple surges ahead of earnings Reuters
01:04PM  Top Health Care Stocks for February 2020 Investopedia
12:44PM  The Dow Is Up 249 Points as Stocks Snap Back on Earnings Strength Barrons.com
12:11PM  US STOCKS-Wall Street rebounds as tech, financials surge Reuters
11:10AM  Stocks - Dow Rebounds as Apple Rallies Into Earnings Investing.com
10:52AM  Allergan to Divest Brazikumab, Zenpep to Close AbbVie Merger Zacks
10:44AM  CORRECTED-US STOCKS-Wall Street recovers from Monday rout on tech, financial support Reuters
10:31AM  Pfizer (PFE) Lags Q4 Earnings & Sales Estimates, Stock Down Zacks
10:09AM  Stock Market Rebounds After Monday's Coronavirus Sell-Off; AMD, Apple, Starbucks Set To Report Investor's Business Daily
09:49AM  Pfizer Stock Could Test 2019 Low Investopedia
09:26AM  Tuesday's Market Minute: Earnings Snapshot Benzinga
09:05AM  CORRECTED-US STOCKS-Wall Street set to recover after turbulent Monday Reuters
08:41AM  Pfizer Stock Is Dropping Because Its Earnings Missed Expectations Barrons.com
08:05AM  Pfizer profit misses estimates, revenue declines as Lyrica sales tumble Reuters
08:03AM  US STOCKS-Wall Street set to recover after turbulent Monday Reuters
07:43AM  Pfizer profit misses as breast cancer drug sales fall short of estimates Reuters
07:38AM  Stock drops of earnings reporters nearly 50 points off the Dow's price MarketWatch
07:37AM  Pfizer Reports Mixed Q4 Earnings Benzinga
07:09AM  Pfizer Reports Earnings Today. Heres What to Expect. Barrons.com
07:05AM  Pfizer's stock falls after profit misses expectations, while revenue was in line MarketWatch
06:53AM  Pfizer posts 9% fall in fourth-quarter revenue Reuters
06:45AM  PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS Business Wire
03:29AM  Pfizer Misses Q4 Earnings Forecast as UpJohn, Lyrica Revenues Slide TheStreet.com
02:09AM  Pfizer's Q4 Earnings Fall More Than Expected Investing.com
Jan-27-20 05:20PM  Here's Why You Should Add BioDelivery Stock to Your Portfolio Zacks
01:15PM  A Preview Of Pfizer's Q4 Earnings Benzinga
10:28AM  Mylan Stock Is Falling Because the Upjohn Deal Wont Soon Help Earnings, Analyst Says Barrons.com
Jan-26-20 11:59AM  The Dow is about to face its stiffest test in years MarketWatch
10:23AM  The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes Benzinga
07:43AM  Pfizer Inc. (NYSE:PFE) Looks Interesting, And It's About To Pay A Dividend Simply Wall St.
12:00AM  Why big pharma sees a remedy in data and AI Financial Times
Jan-24-20 03:16PM  Dow Inc., Merck share losses contribute to Dow's 133-point drop MarketWatch
01:50PM  New partnership aims to ease surging generic drug costs by making its own Yahoo Finance
11:05AM  What Lies Ahead for Healthcare ETFs in Q4 Earnings? Zacks
10:45AM  Dow Inc., Pfizer share losses lead Dow's 29-point drop MarketWatch
09:54AM  Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU Zacks
09:31AM  Will Pfizer's (PFE) BioPharma Unit Boost Its Q4 Earnings? Zacks
Jan-23-20 06:00PM  Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments GuruFocus.com
12:13PM  Drug giant taps U of L for first-of-its kind research center American City Business Journals
10:00AM  Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults Business Wire
09:12AM  The Zacks Analyst Blog Highlights: Pfizer, Wells Fargo, SAP, salesforce.com and Eli Lilly Zacks
08:46AM  Pfizer (PFE) Q4 Earnings Coming Up: What's in the Cards? Zacks
08:13AM  Primary Drivers of the Chinese Economy Investopedia
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, Merck KGaA, Nektar Therapeutics, Syapse, Inc., eFFECTOR Therapeutics, Inc., and Insilico Medicine, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gottlieb ScottDirectorJan 30Buy37.001,00036,9974,000Jan 31 08:06 AM
PFIZER INC10% OwnerSep 17Buy18.0050,000900,0004,593,847Sep 19 04:19 PM
Gottlieb ScottDirectorAug 23Buy34.723,000104,1603,000Aug 26 09:27 AM
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM